Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark A. Spahr
Mark A. Spahr
Esperion Therapeutics Inc.
Internal medicine
Biochemistry
Endocrinology
Biology
Kinase
6
Papers
271
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism
2013
Journal of Lipid Research
Stephen L. Pinkosky
Sergey Filippov
Rai Ajit K. Srivastava
Jeffrey C. Hanselman
Cheryl D. Bradshaw
Timothy R. Hurley
Clay T. Cramer
Mark A. Spahr
Ashley F. Brant
Jacob L. Houghton
Christopher L. Baker
Mark Naples
Khosrow Adeli
Roger S. Newton
Show All
Source
Cite
Save
Citations (119)
Abstract 292: ETC-1002 Reduces Body Weight Gain and Hepatic Triglyceride Content and Improves Glycemic Control in a Mouse Model of Diet-Induced Obesity
2012
Arteriosclerosis, Thrombosis, and Vascular Biology
Jeffrey C. Hanselman
Rai Ajit K. Srivastava
Timothy R. Hurley
Sergey Filippov
Mark A. Spahr
Cheryl D. Bradshaw
Clay T. Cramer
Richard J Lister
Stephen L. Pinkosky
Roger S. Newton
Show All
Source
Cite
Save
Citations (0)
Dominant Negative Effect of TGF-β1 and TNF-α on Basal and IL-6–Induced Lipoprotein(a) and Apolipoprotein(a) mRNA Expression in Primary Monkey Hepatocyte Cultures
1998
Arteriosclerosis, Thrombosis, and Vascular Biology
Randy Ramharack
Derek Barkalow
Mark A. Spahr
Show All
Source
Cite
Save
Citations (79)
Gemfibrozil significantly lowers cynomolgus monkey plasma lipoprotein[a]-protein and liver apolipoprotein[a] mRNA levels.
1995
Journal of Lipid Research
Randy Ramharack
Mark A. Spahr
Gary W. Hicks
K A Kieft
David W. Brammer
L.L. Minton
Roger S. Newton
Show All
Source
Cite
Save
Citations (28)
1